Rijksoverheid

GIPdatabank

Vergoeding 2012-2016 voor ATC-subgroep N05BA : Benzodiazepinederivaten
Raming voor de totale Zvw-populatie

  2012 2013 2014 2015 2016
N05BA01 Diazepam (Stesolid ®) 518.830 567.700 585.760 600.490 579.410
N05BA02 Chloordiazepoxide 103.630 84.742 89.603 84.098 83.091
N05BA04 Oxazepam (Seresta ®) 1.049.400 1.162.300 1.338.600 1.314.800 1.193.000
N05BA05 Clorazepinezuur (di-k-zout) (Tranxene ®) 437.740 467.560 447.240 415.610 414.250
N05BA06 Lorazepam (Temesta ®) 581.980 664.100 821.500 923.590 991.140
N05BA08 Bromazepam 117.840 133.440 151.630 150.840 149.040
N05BA09 Clobazam (Frisium ®) 360.740 366.920 385.790 396.490 399.680
N05BA11 Prazepam (Reapam ®) 29.490 29.213 27.348 26.777 26.178
N05BA12 Alprazolam (Xanax ®) 711.340 750.600 764.320 772.870 765.720
Totaal 3.910.990 4.226.575 4.611.791 4.685.565 4.601.509

Bron: GIP / Zorginstituut Nederland
Geactualiseerd op: 21-11-2017